[HTML][HTML] Current advances in RNA therapeutics for human diseases

H Zogg, R Singh, S Ro - International journal of molecular sciences, 2022 - mdpi.com
Following the discovery of nucleic acids by Friedrich Miescher in 1868, DNA and RNA were
recognized as the genetic code containing the necessary information for proper cell …

Genetically transitional disease: a new concept in genomic medicine

Q Yao, P Gorevic, B Shen, G Gibson - Trends in Genetics, 2023 - cell.com
Traditional classification of genetic diseases as monogenic and polygenic has lagged far
behind scientific progress. In this opinion article, we propose and define a new terminology …

[HTML][HTML] Expanding ACMG variant classification guidelines into a general framework

E Masson, WB Zou, E Génin, DN Cooper, G Le Gac… - Human Genomics, 2022 - Springer
Abstract Background The American College of Medical Genetics and Genomics (ACMG)-
recommended five variant classification categories (pathogenic, likely pathogenic, uncertain …

[HTML][HTML] Tissue-Specific Regulation of CFTR Gene Expression

C Blotas, C Férec, S Moisan - International Journal of Molecular Sciences, 2023 - mdpi.com
More than 2000 variations are described within the CFTR (Cystic Fibrosis Transmembrane
Regulator) gene and related to large clinical issues from cystic fibrosis to mono-organ …

Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians

V Terlizzi, PM Farrell - Current Problems in Pediatric and Adolescent …, 2024 - Elsevier
During the past quarter century, the diagnosis and treatment of cystic fibrosis (CF) have
been transformed by molecular sciences that initiated a new era with discovery of the cystic …

[HTML][HTML] Modifier factors of cystic fibrosis phenotypes: a focus on modifier genes

J Mésinèle, M Ruffin, L Guillot, H Corvol - International Journal of …, 2022 - mdpi.com
Although cystic fibrosis (CF) is recognized as a monogenic disease, due to variants within
the CFTR (Cystic Fibrosis Transmembrane Regulator) gene, an extreme clinical …

Microbiota and fungal-bacterial interactions in the cystic fibrosis lung

E Santos-Fernandez, L Martin-Souto… - FEMS Microbiology …, 2023 - academic.oup.com
The most common genetic hereditary disease affecting Caucasians is cystic fibrosis (CF),
which is caused by autosomal recessive mutations in the CFTR gene. The most serious …

[HTML][HTML] Can bioactive food substances contribute to cystic fibrosis-related cardiovascular disease prevention?

LM Trandafir, OE Frăsinariu, E Țarcă, LI Butnariu… - Nutrients, 2023 - mdpi.com
Advances in cystic fibrosis (CF) care have significantly improved the quality of life and life
expectancy of patients. Nutritional therapy based on a high-calorie, high-fat diet, antibiotics …

Identification of single nucleotide variants in SLC26A9 gene in patients with cystic fibrosis (p. Phe508del homozygous) and its association to Orkambi®(lumacaftor and …

LG Santos, SVN Pereira, AHP Kmit, LC Bonadia… - Gene, 2023 - Elsevier
Background Since patients with cystic fibrosis with different Cystic Fibrosis Transmembrane
Regulator (CFTR) genotypes present a wide response variability for modulator drugs such …

[HTML][HTML] Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies

A Carbone, P Vitullo, S Di Gioia, M Conese - Genes, 2023 - mdpi.com
Cystic fibrosis (CF) is a monogenic syndrome determined by over 2000 mutations in the CF
Transmembrane Conductance Regulator (CFTR) gene harbored on chromosome 7. In …